News and Announcements
Power Ledger wins endorsements worth millions from billionaire Sir Richard Branson
- Published October 23, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Power Ledger has been named the winner of a global technology competition run by billionaire Sir Richard Branson.
- The company has won an endorsement worth millions for their energy network based entirely on blockchain technology.
- Sir Richard Branson and a panel of judges declared Power Ledger the winner at the event held on the entrepreneur’s Necker Island in the Caribbean.
Power ledger are proud to announce that they were named the winner of a global technology competition run by billionaire Sir Richard Branson.
The blockchain-based electricity provider has won an endorsement worth millions.
The Extreme Tech Challenge (XTC) was held on the billionaire entrepreneur’s Necker Island in the Caribbean.
Power ledger were up against world-leading technology companies and state that the win was ‘mind-blowing’ for them.
XTC is a competition designed to allow entrepreneurs to showcase their technologies.
Power ledger will receive access to global tech companies such as Amazon and endorsements worth millions from Mr Branson.
About Power Ledger Pty Ltd
Australia’s first token sale is disrupting the energy sector. POWR token allows you to access the Power Ledger energy trading platform. Start selling power from your own solar panels, or just pay less for your energy bills by purchasing your power directly from your neighbour. Power Ledger is bringing peer-to-peer energy trading to the world.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
